Medication info

Dapadi Tablet 10 mg (Dapagliflozin Propanediol Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Kujoo Pharmaceutical Co., Ltd.
Appearance
Yellow, biconvex, diamond-shaped film-coated tablet
Packaging
28 tablets/PTP [7 tablets/Alu-Alu x 4], 30 tablets/bottle, 28 tablets/bottle
Approval status
Active

MFDS item code 202200564 · Approved 2022.02.07

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes drug treatment, when administered in combination with metformin, the recommended initial dose of this drug is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Kujoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar control issues
  • cardiovascular diseases
  • cardiovascular risk factors
View approved original text

This medication is used to help control blood sugar in patients with type 2 diabetes. It is administered alone or in combination with dietary and exercise therapy to effectively manage blood sugar levels. It is also used in patients who have cardiovascular disease or cardiovascular risk factors and whose blood sugar is not adequately controlled. This medication helps improve blood sugar control and reduce the risk of cardiovascular events.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior experience of diabetes drug treatment, when administered in combination with metformin, the recommended initial dose of this drug is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug is not recommended for the purpose of improving glycemic control. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be administered to certain patients. For example, it should not be used by individuals who are allergic to any of its components, patients with type 1 diabetes, patients with diabetic ketoacidosis, or those undergoing dialysis. Caution should be exercised when prescribing this medication to patients with reduced fluid volume or impaired kidney function. This drug can lower blood pressure or affect kidney function, so special care is needed for the elderly or patients taking diuretics. While taking this medication, symptoms of side effects such as hypoglycemia, genital infections, urinary tract infections, reduced fluid volume, and diabetic ketoacidosis should be carefully monitored. Especially, genital infections may occur more commonly in women, and those with a history of prior infections may have a higher risk of recurrence. The risk of hypoglycemia may increase when this medication is used in conjunction with drugs that can induce hypoglycemia such as insulin or sulfonylureas, and dose adjustments may be necessary. Women who are pregnant or breastfeeding should avoid using this medication, and it should be discontinued if pregnancy is confirmed. The safety and efficacy of this medication have not been established in children, so it is not used in this population. In the event of an overdose, there is no specific antidote, so appropriate treatment should be provided based on symptoms, and careful management of dehydration and hypotension symptoms is required. This medication does not have a significant impact on driving or machine operation, but caution is needed when taken with medications at risk for hypoglycemia. Finally, this medication should be stored in its original container, out of the reach of children, and it is safest not to change the container arbitrarily.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, decreased renal creatinine clearance in early treatment, dyslipidemia, elevated serum creatinine in early treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, sensory loss, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, sequelae, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus, vaginal discharge, menstrual irregularities, itching, urticaria, night sweats, arthralgia, musculoskeletal pain, limb pain, muscular weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, anxiety disorder, enuresis, vertigo

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness.

Appearance and packaging

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

28 tablets/PTP [7 tablets/Alu-Alu x 4], 30 tablets/bottle, 28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.